Drug shown to reduce risk of CV death or hospitalization for heart failure in adults with CV disease and type 2 diabetes, irrespective of their CV risk at study start.
Read More »Yearly Archives: 2018
Late-Onset Diabetes: An Early Sign of Pancreatic Cancer for African Americans and Latinos
According to new study, African Americans with type 2 diabetes mellitus (T2DM) have a higher risk of developing pancreatic cancer relative to other ethnic groups.
Read More »Benefits of Ambulatory Medication Reconciliation in Patients with Diabetes
Researchers seek to determine if implementing process in the ambulatory setting could reducing hospitalization, use of emergency departments.
Read More »Prevalence of Diabetes and Prediabetes in People with Severe Mental Illness
Research suggests racial/ethnic background can also play a role in increased risk of diagnosis.
Read More »Benefits of SGLT2 Inhibitors in Patients With or Without History of CVD
Investigators analyze CVD-REAL study to determine impact of drug class on patients with T2D and HF history.
Read More »Diabetes Treatment Targets: How Many Americans Fall Short?
In the United States, what percentage of patients with diabetes fail to meet national treatment targets for glycemic, blood pressure, or cholesterol control?
A. 12%-22%
B. 24%-31%
C. 33%-49%
D. 51%-58%
Follow the link for the answer. Read More »
A1c Criteria
Which criteria other than fasting blood sugar do you feel is most important before providing an A1c test for your patients -- Weight, Family history, Hypertension, Age, Gender, Amount of physical activity? Follow the link to respond.
Read More »Empagliflozin Doesn’t Up Risk of Bone Fractures
Per pooled data from placebo-controlled trials and data from a head-to-head study with glimepiride
Read More »Alcohol and Diabetes: How Alcohol Affects Diabetes
While there are a number of factors that can negatively impact adherence to self-care in a person with diabetes, this article will focus on diabetes and alcohol: specifically, on how alcohol consumption limits this adherence and affects the overall health of people with diabetes.
Read More »July 19, 2018
Many of our patients use basal insulin with few hypoglycemic problems. Even at large doses the risk of hypoglycemia is small in most of our type 2 insulin using patients. The problem comes when the patient is not adequately controlled and we decide to use mealtime insulin to get them …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.